ClinicalTrials.gov
public full text
Public Domain
Clinical Treatment Research of COVID-19-related Olfactory Dysfunction
Studies have demonstrated that patients with COVID-19- related olfactory dysfunction could improve the olfactory function after olfactory training. But the efficacy of oral corticosteroids is controversial. Some evidences shown that corticosteroid treatment would benefit post-COVID-19 olfactory dysfunction and the purpose of this study is to evaluate its efficacy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Positive long-term outcomes of functional nasal surgery and histological findings in post-COVID-19 olfactory dysfunction#474720
- The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction#1088375
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis#877316
- Chronic Rhinosinusitis With or Without Nasal Polyps Steroid Study#981563
- A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps#1173398
Record · ID 889166
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive